Published Online:
December 8, 2010
This is the protocol for a review and there is no abstract. The objectives are as follows:
We will assess the benefits and harms of an FIO2 equal to or higher than 60% compared with a control FIO2 of 40% or below in the perioperative setting.
We will look at various outcomes, conduct subgroup and sensitivity analyses, examine the role of bias and apply trial sequential analyses (TSA) (Brok 2008; Brok 2009; Thorlund 2009; Wetterslev 2008) to examine the level of evidence for this intervention.